Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.
scientific article published on 20 October 2017
Author/s
author: Herve Avet-Loiseau, Tamás Masszi, Peter Ganly, Antonio Palumbo, Shaji K Kumar, S. Vincent Rajkumar, Jesús San Miguel, Philippe Moreau, Paul G. Richardson, Nizar J Bahlis, Dixie-Lee Esseltine, Helgi van de Velde, Michele Cavo, Alessandra Di Bacco, Ludek Pour, Deborah Berg
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.